Jennifer A. Pietenpol

Author

Also Known As

J A Pietenpol, J Pietenpol, J. A. Pietenpol, J.A Pietenpol, J.A. Pietenpol, JENNIFER A. PIETENPOL, Jennifer A Pietenpol, Jennifer A. Pietenpol, Jennifer Pietenpol, Jennifer A. Pietenpol

408

Publications

26.3K

Citations

H-Index

143

Concepts

All Affiliations

Vanderbilt University Vanderbilt University Medical Center Harvard University

About

Jennifer A. Pietenpol is an author at Vanderbilt University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	48	13.7K
2	Health Sciences	9	9	7.5K
3	Natural Sciences	6	6	2.3K
4	Engineering	4	4	198
5	Nursing	1	1	14

Jennifer A. Pietenpol

108

Publications

21.9K

Citations

H-Index

Page 1

	Year	Citations
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Brian D. Lehmann, Joshua A. Bauer, Xi Chen, Journal of Clinical Investigation Androgen ReceptorBreast OncologyTumor BiologyOncologyTumor Heterogeneity	2011	5.3K
Definition of a consensus binding site for p53 Wafik S. El‐Deiry, Scott E. Kern, Jennifer A. Pietenpol, Nature Genetics Natural SciencesDna ReplicationMolecular BiologyMolecular BaseTumor Biology	1992	2K
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 Jonathan D. Oliner, Jennifer A. Pietenpol, Sam Thiagalingam, Nature Tumor BiologyOncogenic AgentMedicineCancer BiologyTumor Suppressor	1993	1.5K
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection Brian D. Lehmann, Bojana Jovanović, Xi Chen, PLoS ONE Breast OncologyPathologyNeoadjuvant Chemotherapy SelectionTumor BiologyOncology	2016	1.3K
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes Hiroko Masuda, Keith Baggerly, Ying Wang, Clinical Cancer Research	2013	700
TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains Jennifer A. Pietenpol, Roland Stein, Elizabeth Morán, Cell Transcriptional RegulationSignal TransductionC-myc TranscriptionCell RegulationReceptor Tyrosine Kinase	1990	611
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets Justin M. Balko, Jennifer M. Giltnane, Kai Wang, Cancer Discovery	2013	467
Sequence-specific transcriptional activation is essential for growth suppression by p53. Jennifer A. Pietenpol, Takashi Tokino, Sam Thiagalingam, Proceedings of the National Academy of Sciences Cell ProliferationCancer BiologyTumor BiologyTranscriptional RegulationCell Regulation	1994	408
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Jennifer A. Pietenpol, J T Holt, Roland Stein, Proceedings of the National Academy of Sciences C-myc ExpressionImmunologyC-myc GeneCell ProliferationDermatology	1990	396
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression Scott E. Kern, Jennifer A. Pietenpol, Sam Thiagalingam, Science Tumor BiologyOncogenic AgentMedicineTumor Suppressor P53Oncogenic Forms	1992	343

Page 1